AI 9301

This semi-synthetic flavone is the most potent vascular growth inhibitor in several in vitro models and in vivo shows hydroxy radical scavenging properties as well that inhibit the transformation of pre cancerous cells into cancerous cells. The active moiety has a better toxicological profile than an already approved human drug and is thus a perfect candidate for prostate adenocarcinoma prevention and adjunct therapy.

Although discussions are advanced with 2 partners, licensing opportunities and R&D collaborations are welcome.

AI 1005


We found a new indication for this chemical, that is already approved as a drug in many countries at higher dose regimen, as an antibiotic enhancer as it is capable of rendering multiresistant Streptococcus pneumoniae sensitive to penicillin + AI 1005 in mice pneumonia lethal models.

should your company be interested PLS inquire here!

Bonne nouvelle!

Notre SRC est agrée pour le Crédit d'Impôt Recherche. Depuis que le dispositif existe nos clients bénéficient d'un crédit d'impôt en France équivalent au moins à 50 % du montant des études qu'ils nous confient.

Our CRO,part of excellence cluster MEDICEN, allows our client to benefit in France from state incentive up to over 50 p.cent of study cost.